Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Policy & Politics

Calif. Governor Vetoes Bill That Would Have Allowed Purchase of Drugs From Canada for Medi-Cal, ADAP Beneficiaries

October 1, 2004

California Gov. Arnold Schwarzenegger (R) on Thursday vetoed a bill (SB 1333) that would have allowed the state to use lower-priced antiretroviral drugs from Canadian pharmacies for Medi-Cal and AIDS Drug Assistance Program beneficiaries, the San Jose Mercury News reports (LaMar/Folmar, San Jose Mercury News, 10/1). The California Senate in May approved the measure, which would have allowed the state's Department of Health Services to reimburse pharmacies for prescription drugs purchased from Canadian pharmacies (Kaiser Daily HIV/AIDS Report, 5/27). Schwarzenegger said that the measure would have violated federal law and "exposed the state to civil, criminal and tort liability," adding, "We all would like to see low-income, uninsured residents have access to more affordable medicines, but measures such as this oversimplify the complex safety, trade, supply and pricing issues involved in this marketplace" (Lawrence, AP/San Jose Mercury News, 10/1).

Reaction
Michael Weinstein -- president of the AIDS Healthcare Foundation, which sponsored the bill -- said, "The governor today missed the opportunity to demonstrate that he places the well-being of Californians before big business and the profits of drug companies," adding, "AHF is disappointed and saddened by his action on SB 1333. We hope the governor has not fallen for the same drug company promises that have impeded the Medicare prescription drug card program from achieving true discounts" (AHF release, 9/30). Pharmacists, drug makers and many state Republicans "cheered" Schwarzenegger's veto, saying that the measure would have violated a federal drug importation ban and reduced profits for pharmaceutical companies, limiting the amount of drug research they conduct, the Mercury News reports (San Jose Mercury News, 10/1).

Back to other news for October 1, 2004


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement